Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

Medically reviewed by Femi Aremu, PharmD Magnesium supplements are available in many forms, including pills and powder. The ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...